HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) shares traded down 20% during mid-day trading on Wednesday . The stock traded as low as $0.21 and last traded at $0.26. 1,517,795 shares were traded during trading, an increase of 476% from the average session volume of 263,527 shares. The stock had previously closed at $0.32.
HCW Biologics Trading Down 20.0 %
The firm has a market cap of $9.80 million, a P/E ratio of -0.26 and a beta of 0.87. The business’s 50-day moving average is $0.42 and its two-hundred day moving average is $0.50.
HCW Biologics Company Profile
HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.
Featured Articles
- Five stocks we like better than HCW Biologics
- What is Short Interest? How to Use It
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Steel Stocks Soaring After Tariff Announcements
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for HCW Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCW Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
